Literature DB >> 19322256

New Zealand's impact on health in the South Pacific: scope for improvement?

Rosemary Wyber1, Nick Wilson, Michael Baker.   

Abstract

We examined how New Zealand activities impact on health in Pacific Island Countries and Territories (PICTs) in two domains: the provision of development assistance and the impact of trade. The available evidence suggests that New Zealand's official development assistance (ODA) is capably and strategically administered by its development agency, NZAID. However, New Zealand contributes comparatively little of its economic capacity to ODA; only 0.30% of gross national income, with a relatively small proportion spent in the health sector. Increasing this level of ODA and proportional spending on health is likely to be important for enhancing the long-term impact and credibility of the country's development assistance programme. New Zealand has a liberalised trade policy toward the PICTs which is likely to provide economic benefits. However, the country also exports health-damaging products to PICTs such as high-fat mutton flaps and tobacco. Permitting such exports may undermine non-communicable disease control strategies and are a significant area of policy incoherence given other support provided (e.g. for tobacco control). Overall there remains significant scope for New Zealand to contribute more effectively via aid and trade to health in the South Pacific.

Entities:  

Mesh:

Year:  2009        PMID: 19322256

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

1.  Long-term trends in food availability, food prices, and obesity in Samoa.

Authors:  Andrew Seiden; Nicola L Hawley; Dirk Schulz; Sarah Raifman; Stephen T McGarvey
Journal:  Am J Hum Biol       Date:  2012-02-27       Impact factor: 1.937

2.  Perspectives of Fijian Policymakers on the Obesity Prevention Policy Landscape.

Authors:  Anna-Marie Hendriks; Mere Y Delai; Anne-Marie Thow; Jessica S Gubbels; Nanne K De Vries; Stef P J Kremers; Maria W J Jansen
Journal:  Biomed Res Int       Date:  2015-08-25       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.